Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

16.38
Delayed Data
As of Feb 12
 +1.08 / +7.06%
Today’s Change
14.84
Today|||52-Week Range
39.90
-47.11%
Year-to-Date
No recent news for MacroGenics Inc.

Today’s Trading

Previous close15.30
Today’s open15.66
Day’s range15.08 - 16.50
Volume223,216
Average volume (3 months)302,747
Market cap$562.0M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-14,332.99%
Earnings growth (this year)+75.95%
Earnings growth (next 5 years)--
Revenue growth (last year)-17.64%
P/E ratioNM
Price/Sales20.09
Price/Book3.78

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...-1.08-6.78%
SRPTSarepta Therapeutics...+0.62+5.29%
SCMPSucampo Pharmaceutic...+0.08+0.67%
EPZMEpizyme Inc+0.64+7.19%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 17, 2016
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$47.8M
Annual profit (last year)-$38.3M
Net profit margin-80.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers